Evidence map›Paper›PMID 39225241›Full record

ArticlePediatric dermatology

Different de novo mutations in the NF1 gene in a family with neurofibromatosis type 1.

Juan de Dios García-Díaz, Javier Balsa-Vázquez, Ana Rodríguez-Villa, Esther Férriz

Abstract readCase Reports
In one paragraph

Article in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan de Dios García-DíazClinical Genetics Unit, Department of Internal Medicine, University Hospital Príncipe de Asturias, University of Alcalá, Madrid, Spain.ORCID https://orcid.org/0000-0002-4492-3996
Javier Balsa-VázquezClinical Genetics Unit, Department of Internal Medicine, University Hospital Príncipe de Asturias, University of Alcalá, Madrid, Spain.
Ana Rodríguez-VillaDepartment of Dermatology, University Hospital Príncipe de Asturias, University of Alcalá, Madrid, Spain.
Esther FérrizDepartment of Medical Genetics, Health in Code, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The criteria for clinical diagnosis of neurofibromatosis type 1 (NF1) are not sensitive in young children. Recognition is easier when one of their parents has been diagnosed with this condition, and the causal mutation is known. We present a case of a girl with isolated café-au-lait spots, whose father was diagnosed with NF1. However, both were found to carry different de novo mutations in the NF1 gene. This possibility has significant implications for the diagnostic process and genetic counseling.

Indexed as

MutationNeurofibromatosis 1Neurofibromin 1Cafe-au-Lait SpotsFemaleGenes, Neurofibromatosis 1HumansMalePedigreeNeurofibromin 1NF1 protein, humande novo mutationsgenetic counselinggenetic diagnosisneurofibromatosis type 1NF1 gene

Identifiers

PMID39225241
PMCPMC11781016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.